Questionnaire
OtherQuestionnaire on Aortic Valve Disease, HADS-D, SCL-27, MLHFQ
NCT Number: NCT06677528
The objectives of this single center cross-sectional cohort study are to compare symptoms and disease perception of male and female patients with severe aortic stenosis.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany
Background Aortic valve stenosis is a common valvular disease that increases with age and is associated with a poor prognosis when severe (1-3). Treatment options include surgical or interventional replacement of the aortic valve . Awareness of aortic valve stenosis in the general population is low (2% in Europe) (4). Auscultation as a simple screening tool is relatively underused. This leads to a clear underdiagnosis of aortic stenosis especially in patients with only minor or no complaints. In addition, several studies show a marked gender discrepancy: women tend to be diagnosed later, checked less regularly for asymptomatic vitium, and operated on or intervened later (5-7). One possible reason for this could be gender-specific symptom perception. For example, women perceive pain more variably, sensitively, and intensely than men and report more painful conditions. Related to a possible myocardial infarction, women show a greater number of additional, ostensibly nonbreast-related pain symptoms regardless of the presence of chest pain. Both female patients and practitioners are less likely to attribute their prodromal symptoms to heart disease compared with men. Women are generally at higher risk for affective disorders (e.g., depression, anxiety disorders) than men, with greater susceptibility varying with age (8-10).
Literature
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaire on Aortic Valve Disease, HADS-D, SCL-27, MLHFQ
Time frame: From enrollment to the end of FU at 4 weeks
Heart and Diabetes Center North-Rhine Westfalia
Other
Acronym: AWARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05712161
Aortic Stenosis, Aortic Valve Calcification
Tucson, Arizona, United States
View Trial DetailsNCT04310046
Aortic Stenosis, Aortic Valve Disease
Klagenfurt, Austria
View Trial DetailsNCT03735667
Aortic Stenosis, Aortic Valve Disease
Birmingham, Alabama, United States
View Trial DetailsNCT02088554
Aortic Stenosis, Aortic Valve Disease
Los Angeles, California, United States
View Trial Details